LY2828360   Click here for help

GtoPdb Ligand ID: 12751

Synonyms: compound 26 [PMID: 23795771] | LY-2828360
Compound class: Synthetic organic
Comment: LY2828360 is a selective cannabinoid receptor type 2 (CB2) agonist [1]. It is reported to exhibit G protein-biased signalling, and does not recruit arrestin [2].
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 7
Hydrogen bond donors 0
Rotatable bonds 3
Topological polar surface area 56.03
Molecular weight 426.94
XLogP 2.16
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CC1=NC(=C2C(=N1)N(C3CCOCC3)C(=N2)C4=CC=CC=C4Cl)N5CCN(C)CC5
Isomeric SMILES CC1=NC2=C(C(=N1)N3CCN(CC3)C)N=C(N2C4CCOCC4)C5=CC=CC=C5Cl
InChI InChI=1S/C22H27ClN6O/c1-15-24-21(28-11-9-27(2)10-12-28)19-22(25-15)29(16-7-13-30-14-8-16)20(26-19)17-5-3-4-6-18(17)23/h3-6,16H,7-14H2,1-2H3
InChI Key UCMNDPDJRSEZPL-UHFFFAOYSA-N
References
1. Hollinshead SP, Tidwell MW, Palmer J, Guidetti R, Sanderson A, Johnson MP, Chambers MG, Oskins J, Stratford R, Astles PC. (2013)
Selective cannabinoid receptor type 2 (CB2) agonists: optimization of a series of purines leading to the identification of a clinical candidate for the treatment of osteoarthritic pain.
J Med Chem, 56 (14): 5722-33. [PMID:23795771]
2. Lin X, Dhopeshwarkar AS, Huibregtse M, Mackie K, Hohmann AG. (2018)
Slowly Signaling G Protein-Biased CB2 Cannabinoid Receptor Agonist LY2828360 Suppresses Neuropathic Pain with Sustained Efficacy and Attenuates Morphine Tolerance and Dependence.
Mol Pharmacol, 93 (2): 49-62. [PMID:29192123]